← Fields

Science and health

Vaccine safety

34
different names across API lists
1
named by all five models
2.7
names two models share, on average
75%
of names appear in a cited page

What is each chatbot's top 10?

Filled dot: the name is in a page the answer cited. Ring: it is not.

Data

Who does each model name, and at what rank?

Rank each list gave a name; blank means the list left it out.

Data

Who does every model name?

On all five API lists for this field.

Data

Who does only one model name?

On one API list for this field and no other.

Data

How many names do two models share?

Names in common between two API top-10 lists in this field.

GPT-5ClaudeGeminiGrokMuse
GPT-5
3
2
4
2
Claude Sonnet 5
3
2
3
3
Gemini 3.5 Flash
2
2
2
2
Grok 4.5
4
3
2
4
Muse Spark 1.2
2
3
2
4
Data

How many names do the API and the web app share?

Names in common between a model's API top-10 list and its web app's, in this field.

GPT-5ClaudeGeminiGrokMuse
API vs web app
1
–
–
–
–
Data

Do the cited pages back each list?

Each list in this field, by what its cited pages contain.

  • GPT-5 APINo sources cited
  • Claude Sonnet 5 APIMost names in cited pages
  • Gemini 3.5 Flash APIMost names in cited pages
  • Grok 4.5 APISome names in cited pages
  • Muse Spark 1.2 APINo sources cited
  • ChatGPT Web appMost names in cited pages
Data

How many listed names appear in the cited pages?

Share of each list found in a page it cited. Blank: no pages cited.

GPT-5–
Claude Sonnet 570%
Gemini 3.5 Flash100%
Grok 4.540%
Muse Spark 1.2–
ChatGPT90%
Data

Which websites do chatbots cite here?

Cited pages per website, all lists in this field.

who.int5
publichealth.jhu.edu4
kpwashingtonresearch.org2
vaccinesafety.edu2
chop.edu1
clinicaladvisor.com1
science.org1
medscape.com1
hub.jhu.edu1
evat-vax.org1
Data

What did each chatbot answer?

GPT-5API0 sources
  1. No sources cited.
“Top 10” is subjective and depends on what you mean by vaccine safety (clinical trials, post‑licensure surveillance, regulation, risk communication). Here’s a well‑regarded, representative set of experts across those areas: - Nicola P. Klein, MD, PhD — Kaiser Permanente Vaccine Study Center; leads large post‑licensure safety studies (Vaccine Safety Datalink). - Kathryn M. Edwards, MD — Vanderbilt; pediatric infectious diseases, vaccine clinical trials and safety; longtime DSMB and advisory roles. - Steven Black, MD — Co‑founder of the Brighton Collaboration; global vaccine safety surveillance and methodology. - Daniel A. Salmon, PhD, MPH — Director, Johns Hopkins Institute for Vaccine Safety; vaccine safety science and policy. - Tom T. Shimabukuro, MD, MPH, MBA — CDC vaccine safety monitoring leader (VAERS, VSD, v‑safe). - Frank DeStefano, MD, MPH — Former director, CDC Immunization Safety Office; extensive VSD research. - Helen Petousis‑Harris, PhD — University of Auckland; post‑licensure safety research; service with WHO’s Global Advisory Committee on Vaccine Safety. - Elizabeth Miller, FFPH, FRCP — UK public health epidemiologist; landmark post‑licensure vaccine safety evaluations. - Grace M. Lee, MD, MPH — Stanford; pediatrician and health policy researcher; chaired ACIP (2021–2023) with a strong focus on safety and risk–benefit. - Paul A. Offit, MD — Children’s Hospital of Philadelphia; vaccinologist, VRBPAC service, and prominent educator on vaccine safety. If you’re targeting a specific angle (e.g., pregnancy, pediatrics, pharmacovigilance analytics, or regulators like FDA/EMA/WHO), I can tailor the list or add region‑specific names and recent committee roles.
ChatGPTWeb app10 sources

How we read this list: Read from the page text.

  1. 1Professional profilevacsafe.columbia.edu, page unreadable
  2. 2Professional profilevaccinesafety.edu, 1 of 10 names
  3. 3Professional profilevac4eu.org, 2 of 10 names
  4. 4Professional profilencirs.org.au, 1 of 10 names
  5. 5Professional profileinsisvaccine.org, 2 of 10 names
  6. 6Professional profilemedicine.dal.ca, 1 of 10 names
  7. 7Professional profilekpwashingtonresearch.org, 1 of 10 names
  8. 8Current committee memberswho.int, 3 of 10 names
  9. 9How the committee operateswho.int, 0 of 10 names
  10. 10Vaccine safety assessments and reportswho.int, 0 of 10 names
There is no universally accepted ranking of the world's top vaccine-safety experts. However, there are several highly respected scientists, physicians, epidemiologists, and pharmacovigilance specialists whose work focuses specifically on identifying, investigating, and evaluating potential vaccine-related adverse events.For a credible list, I would prioritize experts with:Peer-reviewed research on vaccine safety.Experience investigating adverse events following immunization.Expertise in epidemiology and long-term safety monitoring.Involvement with the WHO, CDC, FDA, or major academic vaccine-safety programs.Experience distinguishing genuine vaccine-related risks from events that happen coincidentally after vaccination.10 leading vaccine-safety experts1. Dr. Robert T. Chen, MD — United States Robert T. ChenA pioneer in vaccine-safety surveillance.Helped establish VAERS, the Vaccine Safety Datalink (VSD), and the Clinical Immunization Safety Assessment (CISA) Network.Particularly knowledgeable about investigating adverse events following vaccination.A strong choice for understanding how vaccine safety is monitored.Professional profile . The Task Force for Global Health+12. Dr. Daniel A. Salmon, PhD, MPH — United States Daniel A. SalmonDirector of the Institute for Vaccine Safety at Johns Hopkins University.Specializes in post-licensure vaccine safety research.Studies vaccine adverse events, risk communication, and childhood vaccination.Professional profile . Hub+13. Professor Anders Hviid, PhD — Denmark Anders HviidHead of Epidemiology Research at Statens Serum Institut.Internationally recognized for large-scale studies examining vaccine safety.Has conducted important research involving MMR, autism, HPV vaccines, and COVID-19 vaccine adverse events.Professional profile . VAC4EU4. Professor Kristine Macartney, MD — Australia Kristine MacartneyDirector of Australia's National Centre for Immunisation Research and Surveillance.Member of the WHO Global Advisory Committee on Vaccine Safety.Has extensive experience in vaccine safety surveillance and pediatric infectious diseases.Professional profile . NCIRS+15. Professor Nick Andrews, PhD — United Kingdom Nick AndrewsSenior statistician at the UK Health Security Agency.Specializes in vaccine safety and effectiveness studies, including large population-based studies.Has authored more than 400 publications.Member of the WHO Global Advisory Committee on Vaccine Safety.Professional profile . VAC4EU+16. Dr. Karina Top, MD, MS — Canada Karina TopProfessor at the University of Alberta.Studies the causes and risk factors of adverse events following immunization.Specializes in evaluating and managing patients with suspected vaccine-related adverse events.Particularly relevant for clinical questions about unusual reactions.Professional profile . InIServices7. Professor Noni MacDonald, MD, MSc — Canada Noni MacDonaldProfessor Emeritus at Dalhousie University.Has substantial expertise in vaccine safety, vaccine communication, and immunization policy.Has worked with the WHO on vaccine-related issues.Professional profile . Dalhousie University+18. Professor Michael Gold, MD — Australia Michael GoldUniversity of Adelaide vaccine-safety expert.Has contributed to WHO work on adverse events following immunization.Particularly relevant to clinical assessment and management of suspected vaccine reactions.World Health Organization+19. Professor Gagandeep Kang, MD, PhD — India Gagandeep KangLeading Indian researcher in infectious diseases and vaccinology.Has contributed to international vaccine-safety work, including WHO advisory activities.Particularly valuable for understanding vaccine evaluation in diverse populations and global public health settings.PubMed+110. Dr. Jennifer Clark Nelson, PhD — United States Jennifer Clark NelsonSenior investigator at Kaiser Permanente Washington Health Research Institute.Has provided statistical leadership for the FDA Sentinel Initiative.Leads safety research within the CDC-sponsored Vaccine Safety Datalink.Particularly strong in detecting and statistically evaluating rare adverse events.Professional profile . Biostatistics+1Where I would startIf your goal is to investigate whether vaccines are safe, I would particularly prioritize these five:Research questionExperts to consultOverall vaccine safetyRobert Chen, Daniel SalmonRare and long-term adverse eventsAnders Hviid, Nick AndrewsClinical assessment of vaccine reactionsKarina Top, Michael GoldPediatric vaccine safetyKristine Macartney, Noni MacDonaldStatistical detection of safety signalsJennifer NelsonAn important additional resource WHO Global Advisory Committee on Vaccine Safety (GACVS)This is one of the most important international scientific bodies for evaluating vaccine safety. Its members include specialists in epidemiology, toxicology, immunology, pharmacology, and clinical medicine.Current committee members How the committee operates Vaccine safety assessments and reports One important distinction: An expert's reputation or institutional affiliation does not automatically make every conclusion correct. For a balanced assessment, look at published research, study methodology, independent replication, financial disclosures, and whether researchers openly acknowledge both known risks and uncertainties.One question that would help me refine this listAre you primarily interested in:Vaccine injuries and adverse reactions — myocarditis, neurological problems, autoimmune conditions, etc.Long-term vaccine safety — potential effects years or decades after vaccination.Childhood vaccine safety — MMR, DTaP, HPV, hepatitis B, and the childhood schedule.COVID-19 vaccine safety — mRNA vaccines, myocarditis, blood clots, and other adverse events.All vaccines — an independent, comprehensive examination of vaccine safety.I can also identify experts who have published research critical of existing vaccine-safety assessments, alongside those who support current vaccine recommendations, so that you can evaluate competing evidence rather than relying on one perspective.
Claude Sonnet 5API6 sources
There isn't an official or universally agreed-upon "top 10" ranking of vaccine safety experts—this is a subjective designation that varies depending on who's compiling the list and what criteria they use (research output, clinical experience, government advisory roles, etc.). However, I can give you a list of widely respected researchers, clinicians, and public health officials who are prominently recognized in the field of vaccine safety science. Let me verify current info first.There's no single official "top 10" ranking of vaccine safety experts—this is subjective and depends on criteria (research output, regulatory experience, clinical trial leadership, etc.). That said, based on current reporting and established credentials, here are 10 widely respected figures in vaccine safety science, policy, and research: 1. **Paul Offit, MD** – Director of the Vaccine Education Center at Children's Hospital of Philadelphia (CHOP) and co-inventor of the rotavirus vaccine; Dr. H Fred Clark co-invented the rotavirus vaccine with colleagues including Dr. Stanley Plotkin and Dr. Paul Offit, Director of the Vaccine Education Center, able to devise a vaccine that induces protective immunity in babies. He's one of the most frequently cited voices on vaccine safety and misinformation. 2. **Stanley Plotkin, MD** – A legendary vaccinologist involved in developing the rubella vaccine and widely regarded as one of the field's senior statesmen. 3. **Daniel Salmon, PhD, MPH** – Director of the Institute for Vaccine Safety at Johns Hopkins; he is a vaccinologist who conducts epidemiological and behavioral studies to assess the safety of vaccines and improve vaccine decision-making. 4. **Steven Black, MD** – A leading international vaccine safety researcher; since 2019, he has co-directed an ambitious, 30-country consortium called the Global Vaccine Data Network, which enables vaccine safety analyses across massive, diverse populations around the world. 5. **Peter Marks, MD, PhD** – Former top FDA vaccine regulator, who has spoken out on the importance of unbiased vaccine safety surveillance; he has warned that "the reduction in emphasis on the unbiased ascertainment of vaccine safety signals, and redirection toward certain specific issues like autism in vaccines, which we know is not true" is dangerous. 6. **Michael Osterholm, PhD, MPH** – Director of CIDRAP at the University of Minnesota, now spearheading the Vaccine Integrity Project; he helped convene leaders across public health and medicine on how to set up an independent reaction team for vaccine safety and effectiveness review. 7. **Harvey Fineberg, MD** – Former president of the National Academy of Medicine, co-chairing the Vaccine Integrity Project; he has expressed concern about the federal response to outbreaks and said "we are trying to ensure that the best science continues to guide decisions about vaccines." 8. **Margaret Hamburg, MD** – Former FDA Commissioner, co-chairing the Vaccine Integrity Project steering committee alongside Fineberg. 9. **Bruce Carleton, PharmD** – Lead investigator at the University of British Columbia studying genetic predispositions to vaccine-related myocarditis as part of the Global Vaccine Data Network; research funded by the grant had progressed to finding 7 genetic variants known to be related to cardiac inflammation in people who got myocarditis postvaccination. 10. **Lisa Jackson, MD, MPH** – Leads vaccine clinical trials at Kaiser Permanente Washington Health Research Institute; she launched the world's first trial of an experimental COVID-19 vaccine—the now-approved NIH-Moderna vaccine—and continues to test the safety and effectiveness of COVID-19 vaccines and boosters. **A note on context:** Vaccine safety expertise has become a politically charged topic in the U.S. recently, with leading vaccine scientists calling for more resources to research vaccine safety and support people with claims of injury, and asking HHS Secretary Robert F. Kennedy Jr., who has a history as an anti-vaccine activist, to "step up." Groups like the **Vaccine Integrity Project** (housed at CIDRAP) have formed specifically because it was created by the University of Minnesota's Center for Infectious Disease Research and Policy to provide evidence on vaccine safety and effectiveness as a resource for clinicians and for medical societies, partly in response to federal-level shifts in vaccine messaging and oversight. If you're looking for experts on a specific vaccine type (e.g., mRNA, childhood immunizations) or a specific safety concern, I can help narrow this down further.
Gemini 3.5 FlashAPI6 sources
  1. 1Faculty Biographies – Institute for Vaccine Safetyvaccinesafety.edu, 2 of 10 names
  2. 2jhu.eduhub.jhu.edu, page unreadable
  3. 3Meet the Team | Expert Vaccine Analysis Team — Expert Vaccine Analysis Teamevat-vax.org, 6 of 10 names
  4. 4georgetown.edugumc.georgetown.edu, 5 of 10 names
  5. 5kpchr.orgresearch.kpchr.org, 1 of 10 names
  6. 6umaryland.edumedschool.umaryland.edu, 1 of 10 names
Evaluating vaccine safety involves rigorous scientific research across multiple disciplines, including epidemiology, immunology, pediatrics, regulatory science, and public health surveillance. The following are 10 internationally recognized experts and researchers who have made significant contributions to vaccine safety, post-licensure monitoring, and public communication regarding immunization: 1. **Dr. Paul Offit** * **Role:** Professor of Pediatrics in the Division of Infectious Diseases at the Children’s Hospital of Philadelphia, and co-inventor of the rotavirus vaccine. * **Focus:** Dr. Offit is a globally prominent voice in vaccine science and safety, known for his extensive writing and research dispelling misinformation regarding vaccines and autism, and for his work on rotavirus safety. 2. **Dr. Daniel A. Salmon** * **Role:** Director of the Institute for Vaccine Safety and Professor of International Health at the Johns Hopkins Bloomberg School of Public Health. * **Focus:** Dr. Salmon specializes in post-licensure vaccine safety, vaccine policy, and the epidemiology of vaccine-preventable diseases, having previously overseen federal vaccine safety activities at the National Vaccine Program Office. 3. **Dr. Peter Hotez** * **Role:** Professor of Pediatrics and Molecular Virology and Microbiology, and Co-Director of the Center for Vaccine Development at Texas Children’s Hospital at Baylor College of Medicine. * **Focus:** A prominent vaccine developer and scientist, Dr. Hotez has dedicated much of his career to creating accessible, safe vaccines for neglected tropical diseases and combating anti-science and anti-vaccine movements. 4. **Dr. Jesse L. Goodman** * **Role:** Professor of Medicine and Infectious Diseases at Georgetown University Medical Center and former Chief Scientist and Director of the Center for Biologics Evaluation and Research (CBER) at the U.S. FDA. * **Focus:** Dr. Goodman is an expert in medical product regulation, infectious diseases, and safety oversight, frequently leading expert panels (such as the Expert Vaccine Analysis Team) assessing vaccine safety and development. 5. **Dr. Walter Orenstein** * **Role:** Professor Emeritus of Medicine, Pediatrics, Epidemiology, and Global Health at Emory University, and former Director of the U.S. Immunization Program at the CDC. * **Focus:** Dr. Orenstein has decades of experience in vaccine program management, vaccine effectiveness, and safety surveillance, playing a foundational role in global smallpox and polio eradication efforts. 6. **Dr. Allison Naleway** * **Role:** Senior Epidemiologist at the Kaiser Permanente Center for Health Research. * **Focus:** Dr. Naleway serves as a principal investigator for the CDC’s **Vaccine Safety Datalink (VSD)**, a critical collaborative project that uses vast electronic health records to monitor real-world vaccine safety, particularly regarding rare adverse events and safety during pregnancy. 7. **Dr. Norman Baylor** * **Role:** President and CEO of Biologics Consulting and former Director of the Office of Vaccines Research and Review at the U.S. FDA. * **Focus:** Dr. Baylor brings deep regulatory expertise regarding how vaccines are evaluated for safety, potency, and purity before and after they receive authorization or licensure. 8. **Dr. Philip Krause** * **Role:** Expert consultant in vaccinology and former Deputy Director of the FDA’s Office of Vaccines Research and Review, as well as Chair of the World Health Organization’s COVID-19 Vaccines Research Expert Group. * **Focus:** Dr. Krause specializes in clinical trial design, regulatory pathways, and the ongoing safety and efficacy evaluation of vaccines globally. 9. **Dr. Matthew Z. Dudley** * **Role:** Associate Research Professor of Epidemiology at the Johns Hopkins Bloomberg School of Public Health and Director of Epidemiology for the Institute for Vaccine Safety. * **Focus:** His research centers on post-licensure vaccine safety, vaccine hesitancy, and improving public health communication surrounding vaccine risks and benefits. 10. **Dr. Kathleen Neuzil** * **Role:** Professor of Medicine and Pediatrics and Director of the Center for Vaccine Development and Global Health at the University of Maryland School of Medicine. * **Focus:** Dr. Neuzil has extensive experience testing vaccines in Phase 1 through Phase 3 clinical trials and serves on national and international advisory groups—such as the WHO's Strategic Advisory Group of Experts (SAGE) on Immunization—evaluating vaccine safety and implementation data.
Grok 4.5API13 sources
  1. 11who.int, 0 of 10 names
  2. 22publichealth.jhu.edu, page unreadable
  3. 33crbcnews.com, 2 of 10 names
  4. 44nam.edu, 1 of 10 names
  5. 55publichealth.jhu.edu, page unreadable
  6. 66nejm.org, page unreadable
  7. 77taskforce.org, page unreadable
  8. 88publichealth.jhu.edu, page unreadable
  9. 99pubmed.ncbi.nlm.nih.gov, 1 of 10 names
  10. 1010statnews.com, 2 of 10 names
  11. 1111usnews.com, page unreadable
  12. 1212politico.com, page unreadable
  13. 1313who.int, 0 of 10 names
I need to identify established experts based on scientific contributions rather than recent political appointments.**There is no official, objective “top 10” ranking of vaccine safety experts**, as expertise is multifaceted (epidemiology, clinical trials, pharmacovigilance/surveillance systems like VAERS/VSD/CISA, biostatistics, immunology, pediatrics, regulatory science, and global standards). Rankings would depend on criteria such as peer-reviewed publications/citations, leadership of safety systems or studies, advisory roles (e.g., CDC ACIP, FDA VRBPAC, WHO GACVS), development of monitoring methods, or clinical evaluation experience.[[1]](https://www.who.int/groups/global-advisory-committee-on-vaccine-safety) The list below draws from leading academic, public health, and regulatory figures with substantial, documented contributions to vaccine safety science (e.g., large epidemiological studies ruling out or quantifying rare risks, building surveillance infrastructure, clinical trial safety monitoring, and systematic evidence reviews). It prioritizes established mainstream scientific contributors over recent political appointees. Many have addressed high-profile issues like autism claims, thimerosal/aluminum adjuvants, rare events (myocarditis, GBS, intussusception), and post-licensure monitoring. Inclusion does not imply agreement on every policy issue.[[2]](https://publichealth.jhu.edu/2025/how-the-us-ensures-vaccine-safety) ### 1. Paul A. Offit, MD Director of the Vaccine Education Center and attending physician in Infectious Diseases at Children’s Hospital of Philadelphia (CHOP); former ACIP and FDA VRBPAC member. Co-inventor of the RotaTeq rotavirus vaccine. Extensive publications (>130 papers) on rotavirus immunity and vaccine safety; author of books and frequent public communicator on safety evidence (e.g., no link to autism). Emphasizes rigorous pre- and post-licensure standards because vaccines are given to healthy people.[[3]](https://www.crbcnews.com/articles/paul-offit) ### 2. Kathryn M. Edwards, MD Professor Emerita of Pediatrics (Infectious Diseases) at Vanderbilt University Medical Center; National Academy of Medicine member. Decades of leadership in vaccine evaluation centers, clinical trials (Hib, pertussis/acellular, influenza, pneumococcal, others), Data Safety Monitoring Boards (including COVID), and CDC’s Clinical Immunization Safety Assessment (CISA) network. Built infrastructure for monitoring adverse events and improving safer formulations (e.g., acellular pertussis).[[4]](https://nam.edu/news-and-insights/building-the-science-of-vaccine-safety/) ### 3. Daniel A. Salmon, PhD, MPH Director of the Institute for Vaccine Safety and Professor of International Health at Johns Hopkins Bloomberg School of Public Health. Former Director of Vaccine Safety at the National Vaccine Program Office. Focuses on post-licensure epidemiology, vaccine refusal risks, safety systems, risk communication, and independent assessments to guide policy/providers/public. Key figure in CISA and related monitoring.[[5]](https://publichealth.jhu.edu/faculty/1015/daniel-salmon) ### 4. Anders Hviid, DrMedSci (or equivalent) Head of Department of Epidemiology Research at Statens Serum Institut (Denmark) and Professor of Pharmacoepidemiology at University of Copenhagen. Leads large nationwide registry cohort studies (often >1 million children) on MMR and autism, thimerosal, aluminum adjuvants and chronic diseases (no increased risks for 50 outcomes including autism/asthma/autoimmune), HPV safety, COVID vaccine batches/events (e.g., myocarditis, TTS), and other topics. Highly influential for population-level safety evidence.[[6]](https://www.nejm.org/doi/full/10.1056/NEJMoa021134) ### 5. Robert T. Chen, MD, MA Scientific Director of the Brighton Collaboration (global standards for adverse events following immunization case definitions and tools); previously long-time CDC leader. Instrumental in creating/modernizing U.S. systems: VAERS, Vaccine Safety Datalink (VSD), CISA. Leads SPEAC (Safety Platform for Emergency Vaccines) and related global efforts for standardized monitoring, especially for new/emergency vaccines. Hundreds of publications; foundational for comparable international safety data.[[7]](https://www.taskforce.org/employees/robert-chen-vaccine-safety/) ### 6. Neal A. Halsey, MD Professor Emeritus, Johns Hopkins Bloomberg School of Public Health; founding/Director Emeritus of the Institute for Vaccine Safety. Extensive work on infectious disease prevention via vaccines, causality assessment of adverse events, guidelines (AAP, ACIP, WHO), and safety science. Authored hundreds of papers/books/chapters; emphasized rigorous epidemiologic methods over temporal associations alone.[[8]](https://publichealth.jhu.edu/2002/halsey-autism) ### 7. Frank DeStefano, MD, MPH Former Director of CDC’s Immunization Safety Office. Led or co-authored numerous VSD studies (e.g., no association between vaccine antigen exposure/"too many too soon" and autism; other outcomes like diabetes, asthma, demyelinating diseases). Key contributor to monitoring systems and evidence summaries on major controversies.[[9]](https://pubmed.ncbi.nlm.nih.gov/23545349/) ### 8. Stanley A. Plotkin, MD Emeritus Professor of Pediatrics (University of Pennsylvania/Wistar Institute); often called a “godfather of vaccines.” Developed the RA 27/3 rubella vaccine (key to MMR and congenital rubella elimination in many places); co-developer of RotaTeq rotavirus vaccine; contributions to others (rabies, etc.). Longtime editor of the definitive textbook *Plotkin’s Vaccines* (covers safety extensively); extensive advisory roles and publications (>900). Deep expertise spanning development through safety evaluation.[[10]](https://www.statnews.com/2026/03/02/stanley-plotkin-profile-godfather-of-vaccines-worried/) ### 9. Cody Meissner, MD Professor of Pediatrics at Geisel School of Medicine at Dartmouth; pediatric infectious diseases specialist. Multiple prior terms on CDC ACIP and FDA advisory committees. Widely regarded for deep knowledge of vaccines, schedules, and safety/efficacy data; has served in expert roles evaluating recommendations.[[11]](https://www.usnews.com/news/health-news/articles/2025-08-04/whos-who-on-robert-f-kennedy-jr-s-vaccine-advisory-panel) ### 10. Additional highly regarded contributors (tied or near-top depending on criteria) - **Martin Kulldorff, PhD**: Biostatistician/epidemiologist; developed key methods used in VSD and CDC vaccine safety surveillance; former Harvard faculty; contributed to systems detecting signals while generally supportive of vaccines (with some COVID-era policy disagreements).[[12]](https://www.politico.com/news/2025/10/29/an-interview-with-the-chair-of-kennedys-controversial-vaccine-panel-00626463) - Others frequently cited: Tom Shimabukuro (CDC safety leadership), Saad B. Omer (epidemiology, trials, coverage), international GACVS members (e.g., Nick Andrews/UK, Hazel Clothier/Australia AusVaxSafety), and figures like Michael Gold or Nicholas Wood (clinical safety surveillance). Systematic reviewers from groups like the Institute for Vaccine Safety or Vaccine Integrity Project also contribute significantly.[[13]](https://www.who.int/groups/global-advisory-committee-on-vaccine-safety/gacvs-members) **Context on the field**: Vaccine safety relies on layered systems (pre-licensure trials with DSMBs; post-licensure passive/active surveillance like VAERS, VSD, PRISM, v-safe, international registries; causality assessments; and independent reviews by IOM/NASEM, WHO GACVS, etc.). Rare serious risks (e.g., intussusception with early rotavirus vaccine, myocarditis with mRNA COVID vaccines, GBS with some flu/J&J) have been detected and quantified by these experts and systems, leading to label changes or withdrawals when warranted. Large studies consistently find no causal links for claimed associations like autism.[[2]](https://publichealth.jhu.edu/2025/how-the-us-ensures-vaccine-safety) Expertise evolves with new vaccines/data, and recent U.S. advisory panel changes (e.g., under HHS) have been controversial, with some appointees viewed as less traditional by mainstream peers. For the latest evidence, consult primary sources: peer-reviewed literature, CDC/FDA/WHO safety pages, Brighton Collaboration standards, Johns Hopkins Institute for Vaccine Safety, CHOP Vaccine Education Center, or GACVS statements. Individual clinicians or researchers should be evaluated by their specific publications and methods rather than titles alone.
Muse Spark 1.2API0 sources
  1. No sources cited.
I'll put together a list of leading vaccine safety experts — searching for top specialists to compile the ranking. There is no single official ranking of vaccine safety experts, but the following 10 are widely recognized by academic, government and global health institutions as leading authorities on vaccine safety, vaccinology, and vaccine confidence: ### 1. Dr. Stanley A. Plotkin Widely regarded as one of the leading figures in vaccine science and known as 'the godfather' of vaccinology. He "developed the rubella vaccine now in standard use throughout the world", is co-developer of the rotavirus vaccine, and author of the reference textbook *Plotkin's Vaccines*. His contributions are "so substantial, they literally named the field's go-to textbook after him". ### 2. Dr. Paul Offit Director of the Vaccine Education Center at Children's Hospital of Philadelphia and former member of the CDC's Advisory Committee on Immunization Practices. He is a "pediatric infectious disease specialist and vaccine inventor at the University of Pennsylvania" and inventor of the rotavirus vaccine, with extensive work on vaccine safety communication. ### 3. Dr. Peter Hotez Co-director of the Center for Vaccine Development at Texas Children's Hospital and "a pediatric infectious disease specialist and vaccine scientist at the Baylor College of Medicine". Co-developer of low-cost vaccines for neglected tropical diseases and frequent advisor on vaccine safety. ### 4. Dr. Kathryn M. Edwards Professor of Pediatrics, Vanderbilt University Medical Center. "Kathryn Edwards has spent her five-decade career building the science of vaccine safety". She "held the Sarah H. Sell and Cornelius Vanderbilt Endowed Chair in Pediatrics" and is described as "an expert in pediatric infectious diseases and vaccine safety at Vanderbilt University". She led the NIH-funded Vanderbilt Vaccine Trials and Evaluation Unit and the CDC-funded Clinical Immunization Safety Assessment (CISA) network, and Vanderbilt was selected by CDC "to lead a consortium of top national experts in vaccine safety in performing timely reviews of adverse vaccine events" with Edwards as principal investigator. ### 5. Prof. Heidi J. Larson Founding Director of The Vaccine Confidence Project (VCP) and "Professor of Anthropology, Risk and Decision Science, Department of Infectious Disease Epidemiology, LSHTM". Her "VCP is a WHO Centre of Excellence on addressing Vaccine Hesitancy". Her research focuses on analysis of social and political factors that affect uptake and vaccine confidence. ### 6. Dr. Michael Osterholm Director of the Center for Infectious Disease Research and Policy (CIDRAP) at the University of Minnesota. The "Vaccine Integrity Project, based at the University of Minnesota's Center for Infectious Disease Research and Policy (CIDRAP)" is led by Osterholm, who is described as "CIDRAP Director". The project conducts "transparent, scientific, evidence-based reviews about vaccine safety, risk, and benefits" and independent systematic reviews of vaccine safety and effectiveness. ### 7. Dr. Kate O'Brien Director of the Department of Immunization, Vaccines and Biologicals at the World Health Organization (WHO). Featured as "WHO's Dr. Kate O'Brien breaks down how vaccines are tested, approved, and monitored even after they reach the public". She oversees WHO's Global Advisory Committee on Vaccine Safety (GACVS) and global vaccine safety policy. ### 8. Dr. Robert Chen "30-year veteran of the U.S. Centers for Disease Control and Prevention (CDC) and currently directs the Task Force for Global Health's Brighton Collaboration". The Brighton Collaboration is the global standard for defining and adjudicating vaccine adverse events, central to vaccine pharmacovigilance. ### 9. Prof. Shabir A. Madhi "Professor of vaccinology at the University of the Witwatersrand in Johannesburg, South Africa" and described as "one of the world's leading vaccinologists and pediatric infectious disease experts". Recipient of the 2026 NFID Maxwell Finland Award and the Albert B. Sabin Gold Medal for seminal contributions to vaccines against pneumonia and diarrheal disease. ### 10. Representatives of Regulatory / WHO Safety Committees Two leading regulatory scientists on WHO's Global Advisory Committee on Vaccine Safety (GACVS): - **Dr. Steven Anderson** - Food and Drug Administration (FDA) - **Dr. Amanda Cohn** - Centers for Disease Control and Prevention (CDC) The GACVS is described as "independent group of 15 international experts formed in 1999 to address global vaccine safety concerns" and the WHO committee that investigates vaccine safety signals globally. Other frequently cited experts on mRNA vaccine safety reviews include **Dr. Manish Sadarangani** teamed with "Dr. Karina Top, Ben Cowling, Heidi Larson and Robin Shattock to compile a review" in The Lancet Group, and for COVID-era policy **Jesse L. Goodman, MD**, former FDA Chief Scientist who chairs the COVID-19 Vaccine Analysis Team (COVAT), an ensemble of "some of America's most trusted vaccine scientific experts" to provide objective analysis of emerging vaccine information. > Rankings of experts are inherently subjective and depend on criteria such as academic citations, leadership of surveillance networks, regulatory roles, and public communication. The individuals above are consistently cited by NIH, CDC, FDA, WHO, and major academic medical centers as authorities on vaccine safety science.